Detalles de la búsqueda
1.
Design, synthesis, and anti-triple negative breast cancer activity of novel Toosendanin derivatives.
Bioorg Med Chem Lett
; 83: 129187, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36781147
2.
Development of actein derivatives as potent anti-triple negative breast cancer agents.
Bioorg Med Chem Lett
; 89: 129307, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37121522
3.
Discovery of heterocyclic substituted dihydropyrazoles as potent anticancer agents.
Bioorg Med Chem Lett
; 48: 128233, 2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34214509
4.
Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor's cytotoxicity.
Int J Cancer
; 145(3): 714-727, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30675909
5.
A silicon-containing aryl/penta-1,4-dien-3-one/amine hybrid exhibits antiproliferative effects on breast cancer cells by targeting the HSP90 C-terminus without inducing heat-shock response.
RSC Med Chem
; 14(12): 2625-2639, 2023 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38107168
6.
YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer.
Cell Death Differ
; 29(6): 1283-1295, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35022570
7.
A feedforward circuit between KLF5 and lncRNA KPRT4 contributes to basal-like breast cancer.
Cancer Lett
; 534: 215618, 2022 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35259457
8.
KLF5-induced lncRNA IGFL2-AS1 promotes basal-like breast cancer cell growth and survival by upregulating the expression of IGFL1.
Cancer Lett
; 515: 49-62, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34052325
9.
Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer.
Cell Death Differ
; 28(10): 2931-2945, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33972717
10.
Detection of organophosphate pesticide using polyaniline and carbon nanotubes composite based on acetylcholinesterase inhibition.
J Nanosci Nanotechnol
; 10(9): 5662-6, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21133088
11.
Novel mutations in BRCA2 intron 11 and overexpression of COX-2 and BIRC3 mediate cellular resistance to PARP inhibitors.
Am J Cancer Res
; 10(9): 2813-2831, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33042619
12.
Mifepristone Derivative FZU-00,003 Suppresses Triple-negative Breast Cancer Cell Growth partially via miR-153-KLF5 axis.
Int J Biol Sci
; 16(4): 611-619, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32025209
13.
Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers.
Int J Biol Sci
; 15(8): 1733-1742, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31360115
14.
Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution.
Oncotarget
; 8(3): 4156-4168, 2017 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27926532
15.
Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials.
Cancer Lett
; 386: 47-56, 2017 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27847302
16.
Design, synthesis, and biological evaluation of a series of benzo[de][1,7]naphthyridin-7(8H)-ones bearing a functionalized longer chain appendage as novel PARP1 inhibitors.
J Med Chem
; 56(7): 2885-903, 2013 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23473053
Resultados
1 -
16
de 16
1
Próxima >
>>